Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea · Delayed Price · Currency is KRW 2,855.00
+40.00 (1.42%)
At close: Nov 13, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 31.15 billion as of November 13, 2026. It is the 35,640th most valuable company in the world and the 2,119th biggest in South Korea. Its market cap has decreased by 34.44% in one year.
Market Cap
31.15B
Enterprise Value
-5.16B
Revenue
65.39B
Global Rank
Country Rank
#2,119 South Korea
PE Ratio
20.85
ChartMarket Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 31.15B, an increase of 148.44%. That is a compound annual growth rate of 4.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 31.15B | -33.60% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hwail Pharmaceutical | 45.60B |
| RP Bio | 44.98B |
| GeneBioTech Co. ,Ltd | 43.48B |
| Jin Yang Pharmaceutical | 43.44B |
| Eagle Veterinary Technology Co.,Ltd | 36.60B |
| Organoidsciences | 33.78B |
| Kyung Nam Pharm | 30.02B |
| HLscience | 29.95B |